Pharmacovigilance and Drug Safety Software Market to Attain a Valuation of US$187.0 Mn Between Period 2017 - 2022
The global pharmacovigilance and drug safety software market is envisioned to rise at a 5.4% CAGR between 2017 and 2022 to attain a valuation of US$187.0 mn by the end of the forecast timeframe. In 2017, the market earned a US$143.6 mn.
View full press release